109 related articles for article (PubMed ID: 21601578)
1. Studies on the reaction of nitric oxide with the hypoxia-inducible factor prolyl hydroxylase domain 2 (EGLN1).
Chowdhury R; Flashman E; Mecinović J; Kramer HB; Kessler BM; Frapart YM; Boucher JL; Clifton IJ; McDonough MA; Schofield CJ
J Mol Biol; 2011 Jul; 410(2):268-79. PubMed ID: 21601578
[TBL] [Abstract][Full Text] [Related]
2. Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).
McDonough MA; Li V; Flashman E; Chowdhury R; Mohr C; Liénard BM; Zondlo J; Oldham NJ; Clifton IJ; Lewis J; McNeill LA; Kurzeja RJ; Hewitson KS; Yang E; Jordan S; Syed RS; Schofield CJ
Proc Natl Acad Sci U S A; 2006 Jun; 103(26):9814-9. PubMed ID: 16782814
[TBL] [Abstract][Full Text] [Related]
3. Kinetic Investigations of the Role of Factor Inhibiting Hypoxia-inducible Factor (FIH) as an Oxygen Sensor.
Tarhonskaya H; Hardy AP; Howe EA; Loik ND; Kramer HB; McCullagh JS; Schofield CJ; Flashman E
J Biol Chem; 2015 Aug; 290(32):19726-42. PubMed ID: 26112411
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for binding of the renal carcinoma target hypoxia-inducible factor 2α to prolyl hydroxylase domain 2.
Figg WD; Fiorini G; Chowdhury R; Nakashima Y; Tumber A; McDonough MA; Schofield CJ
Proteins; 2023 Nov; 91(11):1510-1524. PubMed ID: 37449559
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and biophysical analyses of hypoxia sensing prolyl hydroxylases from
Liu T; Abboud MI; Chowdhury R; Tumber A; Hardy AP; Lippl K; Lohans CT; Pires E; Wickens J; McDonough MA; West CM; Schofield CJ
J Biol Chem; 2020 Dec; 295(49):16545-16561. PubMed ID: 32934009
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hypoxia-inducible factor-prolyl hydroxylation protects from cyclophosphamide-induced bladder injury and urinary dysfunction.
Clayton DB; Tong CMC; Li B; Taylor AS; De S; Mason MD; Dudley AG; Davidoff O; Kobayashi H; Haase VH
Am J Physiol Renal Physiol; 2022 Jul; 323(1):F81-F91. PubMed ID: 35499237
[TBL] [Abstract][Full Text] [Related]
7. Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion.
Yeoh KK; Chan MC; Thalhammer A; Demetriades M; Chowdhury R; Tian YM; Stolze I; McNeill LA; Lee MK; Woon ECY; Mackeen MM; Kawamura A; Ratcliffe PJ; Mecinović J; Schofield CJ
Org Biomol Chem; 2013 Feb; 11(5):732-745. PubMed ID: 23151668
[TBL] [Abstract][Full Text] [Related]
8. Investigating the contribution of the active site environment to the slow reaction of hypoxia-inducible factor prolyl hydroxylase domain 2 with oxygen.
Tarhonskaya H; Chowdhury R; Leung IK; Loik ND; McCullagh JS; Claridge TD; Schofield CJ; Flashman E
Biochem J; 2014 Nov; 463(3):363-72. PubMed ID: 25120187
[TBL] [Abstract][Full Text] [Related]
9. Zebrafish mutants in egln1 display a hypoxic response and develop polycythemia.
Dou X; Chen Z; Liu Y; Li Y; Ye J; Lu L
Life Sci; 2024 May; 344():122564. PubMed ID: 38492922
[TBL] [Abstract][Full Text] [Related]
10. Inverse solvent isotope effects demonstrate slow aquo release from hypoxia inducible factor-prolyl hydroxylase (PHD2).
Flagg SC; Giri N; Pektas S; Maroney MJ; Knapp MJ
Biochemistry; 2012 Aug; 51(33):6654-66. PubMed ID: 22747465
[TBL] [Abstract][Full Text] [Related]
11. SM-20, EGL-9, and the EGLN family of hypoxia-inducible factor prolyl hydroxylases.
Freeman RS; Hasbani DM; Lipscomb EA; Straub JA; Xie L
Mol Cells; 2003 Aug; 16(1):1-12. PubMed ID: 14503838
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.
Holt-Martyn JP; Chowdhury R; Tumber A; Yeh TL; Abboud MI; Lippl K; Lohans CT; Langley GW; Figg W; McDonough MA; Pugh CW; Ratcliffe PJ; Schofield CJ
ChemMedChem; 2020 Feb; 15(3):270-273. PubMed ID: 31751494
[TBL] [Abstract][Full Text] [Related]
13. Oxygen sensing strategies in mammals and bacteria.
Taabazuing CY; Hangasky JA; Knapp MJ
J Inorg Biochem; 2014 Apr; 133():63-72. PubMed ID: 24468676
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of prolyl 4-hydroxylase from Bacillus anthracis.
Culpepper MA; Scott EE; Limburg J
Biochemistry; 2010 Jan; 49(1):124-33. PubMed ID: 19947658
[TBL] [Abstract][Full Text] [Related]
15. PHD1-3 oxygen sensors in vivo-lessons learned from gene deletions.
Jucht AE; Scholz CC
Pflugers Arch; 2024 Mar; ():. PubMed ID: 38509356
[TBL] [Abstract][Full Text] [Related]
16. A mitochondrial EglN1-AMPKα axis drives breast cancer progression by enhancing metabolic adaptation to hypoxic stress.
Jiang W; Zhang M; Gao C; Yan C; Gao R; He Z; Wei X; Xiong J; Ruan Z; Yang Q; Li J; Li Q; Zhong Z; Zhang M; Yuan Q; Hu H; Wang S; Hu MM; Cai C; Wu GS; Jiang C; Zhang YL; Zhang CS; Zhang J
EMBO J; 2023 Oct; 42(20):e113743. PubMed ID: 37661833
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.
Yeh TL; Leissing TM; Abboud MI; Thinnes CC; Atasoylu O; Holt-Martyn JP; Zhang D; Tumber A; Lippl K; Lohans CT; Leung IKH; Morcrette H; Clifton IJ; Claridge TDW; Kawamura A; Flashman E; Lu X; Ratcliffe PJ; Chowdhury R; Pugh CW; Schofield CJ
Chem Sci; 2017 Nov; 8(11):7651-7668. PubMed ID: 29435217
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in PHD2-mediated hydroxylation of HIF2α underlies Pacak-Zhuang syndrome.
Ferens FG; Taber CC; Stuart S; Hubert M; Tarade D; Lee JE; Ohh M
Commun Biol; 2024 Feb; 7(1):240. PubMed ID: 38418569
[TBL] [Abstract][Full Text] [Related]
19. Subcellular Energetics and Metabolism: Potential Therapeutic Applications.
Thiele RH
Anesth Analg; 2017 Jun; 124(6):1872-1885. PubMed ID: 28277320
[TBL] [Abstract][Full Text] [Related]
20. Understanding hypoxia signalling in cells--a new therapeutic opportunity?
Ratcliffe PJ
Clin Med (Lond); 2006; 6(6):573-8. PubMed ID: 17228556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
